2020-22481. Medicare Program; Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program; Correction
-
Start Preamble
AGENCY:
Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION:
Final rule; correction.
SUMMARY:
This document corrects technical errors that appeared in the final rule published in the Federal Register on June 2, 2020 entitled “Medicare Program; Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program.”
DATES:
Effective date: This correcting document is effective on October 13, 2020.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Cali Diehl, (410) 786-4053 or Christopher McClintick, (410) 786-4682—General Questions.
Kimberlee Levin, (410) 786-2549—Part C Issues.
Stacy Davis, (410) 786-7813—Part C and D Payment Issues.
Melissa Seeley, (212) 616-2329—D-SNP Issues.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
I. Background
In FR Doc. 2020-11342 of June 2, 2020 (85 FR 33796), there were a number of technical errors that are identified and corrected in this correcting document. The provisions in this correction document are effective as if they had been included in the document published June 2, 2020. Accordingly, the corrections are effective August 3, 2020.
II. Summary of Errors
On page 33820, in our discussion of dual eligible special needs plans, we inadvertently included a disclaimer that was not applicable to the published final rule.
On pages 33876 and 33877, in our discussion of the information collection requirements regarding Special Supplemental Benefits for the Chronically Ill (SSBCI), we inadvertently identified the wrong Paperwork Reduction Act package in our narrative and omitted several Office of Management and Budget (OMB) control numbers from Table 3.
On page 33881, in our discussion of the information collection requirements regarding medical savings account (MSA) medical loss ratio (MLR), we made inadvertent errors the amount of time it would take beneficiaries to complete an enrollment form.
On page 33883, in the table that provides a summary of the annual information collection burden (Table 6), we made the following typographical errors:
- In the table title, we included the term “requirements” instead of “burden”.Start Printed Page 64402
- In the SSBCI entries there were errors in the identification numbers in the “OMB Control No.” column.
- In the MSA MLR entries, there were errors in the values and numbers for the “Regulatory citation”, “OMB Control No.”, “Total number of respondents”, and the “Total number of responses”.
On pages 33889 and 33890, in the table that displays the per-year calculations regarding kidney acquisition costs (Table 11), we made inadvertent errors in the table title (we omitted “s” in the term “costs”). Additionally, on page 33890, the column headings are listed for the years 2013 to 2020 instead of 2021 to 2030.
III. Waiver of Proposed Rulemaking
Under 5 U.S.C. 553(b) of the Administrative Procedure Act (APA), the agency is required to publish a notice of the proposed rule in the Federal Register before the provisions of a rule take effect. Similarly, section 1871(b)(1) of the Act requires the Secretary to provide for notice of the proposed rule in the Federal Register and provide a period of not less than 60 days for public comment. In addition, section 553(d) of the APA, and section 1871(e)(1)(B)(i) of the Act mandate a 30-day delay in effective date after issuance or publication of a rule. Sections 553(b)(B) and 553(d)(3) of the APA provide for exceptions from the notice and comment and delay in effective date APA requirements; in cases in which these exceptions apply, sections 1871(b)(2)(C) and 1871(e)(1)(B)(ii) of the Act provide exceptions from the notice and 60-day comment period and delay in effective date requirements of the Act as well. Section 553(b)(B) of the APA and section 1871(b)(2)(C) of the Act authorize an agency to dispense with normal rulemaking requirements for good cause if the agency makes a finding that the notice and comment process are impracticable, unnecessary, or contrary to the public interest. In addition, both section 553(d)(3) of the APA and section 1871(e)(1)(B)(ii) of the Act allow the agency to avoid the 30-day delay in effective date where such delay is contrary to the public interest and an agency includes a statement of support.
Section 553(d) of the APA ordinarily requires a 30-day delay in effective date of final rules after the date of their publication in the Federal Register. This 30-day delay in effective date can be waived, however, if an agency finds for good cause that the delay is impracticable, unnecessary, or contrary to the public interest, and the agency incorporates a statement of the findings and its reasons in the rule issued.
We believe that this correcting document does not constitute a rule that would be subject to the notice and comment or delayed effective date requirements of the APA or section 1871 of the Act. This correcting document corrects technical errors in the preamble and regulation text of the final rule but does not make substantive changes to the policies that were adopted in the final rule. As a result, this correcting document is intended to ensure that the information in the final rule accurately reflects the policies adopted in that final rule.
In addition, even if this were a rule to which the notice and comment procedures and delayed effective date requirements applied, we find that there is good cause to waive such requirements. Undertaking further notice and comment procedures to incorporate the corrections in this document into the final rule or delaying the effective date would be contrary to the public interest because it is in the public's interest to ensure that final rule accurately reflects our policies. Furthermore, such procedures would be unnecessary, as we are not altering payment eligibility or benefit methodologies or policies, but rather, simply implementing correctly the policies that we previously proposed, received comment on, and subsequently finalized. This correcting document is intended solely to ensure that the final rule accurately reflects these policies. Therefore, we believe we have good cause to waive the notice and comment and effective date requirements.
IV. Correction of Errors
In FR Doc. 2020-11342 of June 2, 2020 (85 FR 33796), make the following corrections:
1. On page 33820, lower third of the page, the text box that includes the phrase “DISCLAIMER: Based on the tight time constraints and the need to expedite” is corrected by removing the text box.
2. On page 33876, lower three-fourths of the page (after the table), second column, sixth full paragraph, lines 6 and 7, the reference to “control number 0938-0763 (CMS-R-262)” is corrected to read “control number 0938-0753 (CMS-R-267)”.
3. On page 33877, lower third of the page, the table titled “TABLE 3—SUMMARY OF BURDEN FOR SSBCI AT § 422.102” is corrected by correcting the third column (OMB Control No.) for the listed entries (SSBCI provisions) to read as follows:
Provision Regulatory citation OMB Control No. Subject Number of respondents Total number of responses Time per response (hr) Total time (hr) Labor cost ($/hr) Annual cost ($) SSBCI § 422.102(f)(3)(i) 0938-0753 SSBCI: Criteria (Initial Software) 234 1 12 2808 103.33 96,717 SSBCI § 422.102(f)(3)(i) 0938-0753 SSBCI: Criteria (Physician review) 234 1 36 8424 193.7 1,631,729 SSBCI § 422.102(f)(3)(i) 0938-0753 SSBCI: Criteria (Software updates) 234 1 5 1170 85.26 99,754 SSBCI § 422.102(f)(3)(ii) 0938-0753 Written criteria 234 1 2 468 56.34 26,367 SSBCI § 422.102(f)(3)(iii) 0938-0753 Enrollee eligibility 234 1 9 2106 86.95 179,465 4. On page 33881, first column, fourth full paragraph, line 8, the phrase “0.5 hours at $25.72/hr” is corrected to read “0.3333 hours at $25.72/hr”
5. On page 33883, in the table titled “TABLE 6—ANNUAL INFORMATION COLLECTION REQUIREMENTS” the table is corrected by—
a. Correcting the table title “TABLE 6—ANNUAL INFORMATION COLLECTION REQUIREMENTS” to read “TABLE 6—ANNUAL INFORMATION COLLECTION BURDEN”.
b. Correcting the second (Regulatory citation), third (OMB Control No.), sixth (Total number of respondents), and seventh columns (Total number of responses) for the listed entry (third row the first MSA MLR provision) to read as follows:Start Printed Page 64403
Provision Regulatory citation OMB Control No. Respondent type Response summary Total number of respondents Total number of responses Time per response (hr) Total annual time (hr) Labor cost ($/hr) Total annual cost ($) MSA MLR § 422.2440 0938-NEW Enrollees MSA MLR: Filling out enrollment forms. 2,765 2,765 0.3333 922 25.72 23,705 c. Correcting the identification numbers in third column (OMB Control No.) for the listed entries (SSBCI provisions) to read as follows:
Provision Regulatory citation OMB Control No. Respondent type Response summary Total number of respondents Total number of responses Time per response (hr) Total annual time (hr) Labor cost ($/hr) Total annual cost ($) SSCBI § 422.102(f)(3)(i) 0938-0753 MA Plans SSBCI: Criteria (initial software update) 234 1 12 2808 103.33 96,717 SSCBI § 422.102(f)(3)(i) 0938-0753 MA Plans SSBCI: Criteria (Annual physician review) 234 1 36 8424 193.7 1,631,729 SSCBI § 422.102(f)(3)(i) 0938-0753 MA Plans SSBCI: Criteria (Software updates) 234 1 5 1170 85.26 99,754 SSCBI § 422.102(f)(3)(ii) 0938-0753 MA Plans SSBCI: Documentation 234 1 2 468 56.34 26,367 SSCBI § 422.102(f)(3)(iii) 0938-0753 MA Plans SSBCI: Enrollee records 234 1 9 702 86.95 61,039 d. Correcting the second (Regulatory citation) and seventh columns (Total number of responses) for the listed entries (the specified MSA MLR provisions) to read as follows:
Provision Regulatory citation OMB Control No. Respondent type Response summary Total number of respondents Total number of responses Time per response (hr) Total annual time (hr) Labor cost ($/hr) Total annual cost ($) MSA MLR § 422.2440 0938-0753 MA Plans MSA MLR: Notify enrollees 8 2,765 0.0167 46 77.14 3,548 MSA MLR § 422.2440 0938-0753 MA Plans MSA MLR: Submit to CMS 8 2,765 0.0167 46 77.14 3,548 MSA MLR § 422.2440 0938-0753 MA Plans MSA MLR: Archive 8 2,765 0.0833 230 36.82 8,481 e. Correcting column 2 (Regulatory citation) for the listed entry (the specified MSA MLR provision) to read as follows:
Provision Regulatory citation OMB Control No. Respondent type Response summary Total number of respondents Total number of responses Time per response (hr) Total annual time (hr) Labor cost ($/hr) Total annual cost ($) MSA MLR § 422.2440 0938-1252 MA Plans MSA MLR: Calculation of the deductible factor 8 8 0.0833 0.6664 116.32 78 6. On pages 33889 and 33890, in the table titled “Table 11, Per-Year Calculations, Representing the Pre-Statute Baseline Based on Medicare FFS Coverage of Kidney Acquisition Cost”, the table title and table are corrected to read as follows:
Start SignatureTable 11—Per-Year Calculations, Representing the Pre-Statute Baseline Based on Medicare FFS Coverage of Kidney Acquisition Costs
2013 2014 2015 2016 2017 2018 2019 2020 Kidney Acquisition Costs (PMPM): 1.72 1.82 1.95 2.08 2.20 2.34 2.49 2.65 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2021-2030 Kidney Acquisition Costs (PMPM): 2.82 3.00 3.20 3.40 3.62 3.85 4.10 4.36 4.64 4.94 Medicare Advantage Enrollment Projection (000's): 24,690 25,624 26,508 27,380 28,237 29,070 29,861 30,607 31,313 32,035 Gross Savings ($Millions): 836.2 923.5 1,016.6 1,117.4 1,226.3 1,343.4 1,468.4 1,601.7 1,743.7 1,898.4 13,175.6 Average government share of Gross Savings: 83.0% 83.0% 83.0% 83.1% 83.2% 83.2% 83.2% 83.4% 83.4% 83.4% Net of Part B Premium: 85.6% 85.6% 85.5% 85.4% 85.3% 85.2% 85.0% 84.9% 84.9% 84.9% Net Savings ($Millions): 594.1 655.7 721.5 792.3 869.5 951.7 1,038.9 1,134.1 1,235.9 1,345.6 9,339.3 Start Printed Page 64404End Signature End Supplemental InformationDated: October 1, 2020.
Wilma M. Robinson,
Deputy Executive Secretary to the Department, Department of Health and Human Services.
[FR Doc. 2020-22481 Filed 10-8-20; 8:45 am]
BILLING CODE 4120-01-P
Document Information
- Effective Date:
- 10/13/2020
- Published:
- 10/13/2020
- Department:
- Centers for Medicare & Medicaid Services
- Entry Type:
- Rule
- Action:
- Final rule; correction.
- Document Number:
- 2020-22481
- Dates:
- Effective date: This correcting document is effective on October 13, 2020.
- Pages:
- 64401-64404 (4 pages)
- Docket Numbers:
- CMS-4190-CN
- RINs:
- 0938-AT97: Contract Year 2021 Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid, and Medicare Cost Plans (CMS-4190)
- RIN Links:
- https://www.federalregister.gov/regulations/0938-AT97/contract-year-2021-policy-and-technical-changes-to-the-medicare-advantage-medicare-prescription-drug
- PDF File:
- 2020-22481.pdf
- Supporting Documents:
- » Medicare Program: Maximum Out-of-Pocket Limits and Service Category Cost Sharing Standards
- » Medicare and Medicaid Programs: Contract Year 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, etc.; Corrections
- » Medicare and Medicaid Programs: Contract Year 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly
- » Medicare Program: Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program; Correction
- » Medicare Program: Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program
- » Medicare and Medicaid Programs: Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly
- » Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program for Contract Year 2021 (CMS-4190-P)
- CFR: (3)
- 42 CFR 417
- 42 CFR 422
- 42 CFR 423